Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 14.17 USD -1.25% Market Closed
Market Cap: $421.6m

Wall Street
Price Targets

CLPT Price Targets Summary
Clearpoint Neuro Inc

Wall Street analysts forecast CLPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLPT is 28.56 USD with a low forecast of 28.28 USD and a high forecast of 29.4 USD.

Lowest
Price Target
28.28 USD
100% Upside
Average
Price Target
28.56 USD
102% Upside
Highest
Price Target
29.4 USD
107% Upside
Clearpoint Neuro Inc Competitors:
Price Targets
LEGN
Legend Biotech Corp
279% Upside

Revenue
Forecast

18% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Clearpoint Neuro Inc's revenue is 18%. The projected CAGR for the next 3 years is 34%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLPT's stock price target?
Price Target
28.56 USD

According to Wall Street analysts, the average 1-year price target for CLPT is 28.56 USD with a low forecast of 28.28 USD and a high forecast of 29.4 USD.

What is Clearpoint Neuro Inc's Revenue forecast?
Projected CAGR
34%

For the last 13 years the compound annual growth rate for Clearpoint Neuro Inc's revenue is 18%. The projected CAGR for the next 3 years is 34%.

Back to Top